Abbott Laboratories
In Mason Hawkins's portfolio · Longleaf Partners
Ticker ABT
Still in the portfolio as of Q3 2026. Every quarter it shows up in a Longleaf Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | No change | 836,792 | 4.5% |
| Q2 2026 | Buy | 840,747 | 4.0% |
| Q1 2015 | Sell | 0 | |
| Q4 2014 | Reduce 28% | 8,977,941 | 2.3% |
| Q3 2014 | Reduce 9% | 12,483,566 | 2.8% |
| Q2 2014 | No change | 13,687,877 | 3.0% |
| Q1 2014 | Add 2% | 13,747,344 | 2.9% |
| Q4 2013 | Reduce 2% | 13,445,344 | 2.5% |
| Q3 2013 | Reduce 5% | 13,727,856 | 2.3% |
| Q2 2013 | First 13F | 14,418,305 | 2.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.